270 related articles for article (PubMed ID: 10546994)
1. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
[TBL] [Abstract][Full Text] [Related]
2. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
3. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
[TBL] [Abstract][Full Text] [Related]
4. Influence of VIP on prolactinemia in turkey anterior pituitary cells: role of cAMP second messenger in VIP-induced prolactin gene expression.
Kang SW; Youngren OM; El Halawani ME
Regul Pept; 2002 Nov; 109(1-3):39-44. PubMed ID: 12409212
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
6. Rapid glucocorticoid inhibition of vasoactive intestinal peptide-induced cyclic AMP accumulation and prolactin release in rat pituitary cells in culture.
Rotsztejn WH; Dussaillant M; Nobou F; Rosselin G
Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7584-8. PubMed ID: 6278481
[TBL] [Abstract][Full Text] [Related]
7. Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey.
Youngren OM; Chaiseha Y; El Halawani ME
Neuroendocrinology; 1998 Nov; 68(5):319-25. PubMed ID: 9822799
[TBL] [Abstract][Full Text] [Related]
8. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
9. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
Mau SE
J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
[TBL] [Abstract][Full Text] [Related]
10. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a direct anterior pituitary site of delta-9-tetrahydrocannabinol action.
Murphy LL; Newton SC; Dhali J; Chávez D
Pharmacol Biochem Behav; 1991 Nov; 40(3):603-7. PubMed ID: 1725461
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
Bonnin A; Ramos JA; Rodríguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
[TBL] [Abstract][Full Text] [Related]
14. Prolactin release by vasoactive intestinal polypeptide in rats.
Kato Y; Iwasaki Y; Iwasaki J; Abe H; Yanaihara N; Imura H
Endocrinology; 1978 Aug; 103(2):554-8. PubMed ID: 744101
[TBL] [Abstract][Full Text] [Related]
15. Delta 9-tetrahydrocannabinol suppression of prolactin secretion in the rat: lack of direct pituitary effect.
Hughes CL; Everett JW; Tyrey L
Endocrinology; 1981 Sep; 109(3):876-80. PubMed ID: 6266813
[TBL] [Abstract][Full Text] [Related]
16. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
17. Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system.
Lara JI; Lorenzo MJ; Cacicedo L; Tolón RM; Balsa JA; López-Fernández J; Sánchez-Franco F
Endocrinology; 1994 Dec; 135(6):2526-32. PubMed ID: 7988440
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide increases the liberation of arachidonate from anterior pituitary cells in vitro.
Judd AM
Life Sci; 1995; 57(18):1641-6. PubMed ID: 7475904
[TBL] [Abstract][Full Text] [Related]
19. Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments.
Pizzi M; Arrighi V; Galli P; Memo M; Spano PF
Eur J Endocrinol; 1994 Apr; 130(4):361-5. PubMed ID: 8162165
[TBL] [Abstract][Full Text] [Related]
20. Effect of ionotropic and metabotropic glutamate agonists and D-aspartate on prolactin release from anterior pituitary cells.
Pampillo M; Theas S; Duvilanski B; Seilicovich A; Lasaga M
Exp Clin Endocrinol Diabetes; 2002 May; 110(3):138-44. PubMed ID: 12012275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
